Empowering New Breakthroughs in Domestic Pharmaceuticals: Alioth Alidep® Depth Filter Involved in China’s First 10,000L Biosimilar Production Line
Recently, China’s pharmaceutical industry has achieved a landmark advancement—the country’s first 10,000L biosimilar production line, constructed by Nanjing Shunxin Pharmaceutical (a subsidiary of Chia Tai Tianqing Pharmaceutical Group), has officially received marketing approval. As a pivotal collaborator in the deep filtration process of this production line, Alioth’s Alidep® Depth Filter has played a critical role in enabling the client to overcome industrialization challenges in large-scale biopharmaceutical manufacturing, jointly propelling China’s biopharmaceutical sector into a new era of growth.
Domestic 10,000L Production Line Launched
Biopharmaceutical Industrialization Capability Scales New Heights
The production of biopharmaceuticals, particularly antibody drugs, has long been hindered by complex manufacturing processes and heavy reliance on imported equipment and key materials. The approval of China’s first 10,000L biosimilar production line marks a significant leap in the nation’s capacity for large-scale biopharmaceutical industrialization, establishing a new benchmark for the commercial-scale production of biosimilars.
As a strategic partner of Chia Tai Tianqing, Alioth has been deeply involved in optimizing the deep filtration process of this production line. By deploying its cutting-edge Alidep® Depth Filter technology, Alioth has supported the client throughout the entire journey—from process validation to commercial production—ensuring stable and efficient operations.
Technological Innovation
Alioth’s Alidep® Depth Filter Drives Efficient Filtration
In large-scale biosimilar production, deep filtration is a critical step for ensuring product safety and quality. Leveraging its proprietary Alidep® Depth Filter technology, Alioth has delivered:
- Customized Filtration Solutions: Tailored membrane material selection and flow rate optimization to meet the demands of large-scale production, ensuring efficient removal of impurities.
- Process Stability Assurance: A rigorously validated filter production system to guarantee batch-to-batch consistency and minimize risks in large-scale manufacturing.
- Localization Breakthrough: Cost-effective solutions to reduce dependence on imported products, helping clients achieve cost savings and operational efficiency.
From laboratory research to commercialization, and from technological innovation to industrial application, Alioth remains committed to its mission of “creating value for clients” by addressing their production challenges. Looking ahead, Alioth will continue to advance its expertise in bioprocessing technologies, collaborating with industry partners to contribute to China’s pharmaceutical innovation and global competitiveness.
Alioth Alidep® Depth Filter
